Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 355

    1.

    Modulation of the renal response to ACE inhibition by ACE insertion/deletion polymorphism during hyperglycemia in normotensive, normoalbuminuric type 1 diabetic patients.

    Weekers L, Bouhanick B, Hadjadj S, Gallois Y, Roussel R, Pean F, Ankotche A, Chatellier G, Alhenc-Gelas F, Lefebvre PJ, Marre M.

    Diabetes. 2005 Oct;54(10):2961-7.PMID: 16186399 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Renal changes on hyperglycemia and angiotensin-converting enzyme in type 1 diabetes.

    Marre M, Bouhanick B, Berrut G, Gallois Y, Le Jeune JJ, Chatellier G, Menard J, Alhenc-Gelas F.

    Hypertension. 1999 Mar;33(3):775-80.PMID: 10082486 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Angiotensin converting enzyme gene polymorphism and renal hemodynamic function in early diabetes.

    Miller JA, Scholey JW, Thai K, Pei YP.

    Kidney Int. 1997 Jan;51(1):119-24.PMID: 8995725 [PubMed - indexed for MEDLINE]Related articles

    4.

    Effect of the insertion/deletion polymorphism of the angiotensin-converting enzyme gene on response to angiotensin-converting enzyme inhibitors in patients with heart failure.

    O'Toole L, Stewart M, Padfield P, Channer K.

    J Cardiovasc Pharmacol. 1998 Dec;32(6):988-94.PMID: 9869506 [PubMed - indexed for MEDLINE]Related articles

    5.

    Long-term renoprotective effects of losartan in diabetic nephropathy: interaction with ACE insertion/deletion genotype?

    Andersen S, Tarnow L, Cambien F, Rossing P, Juhl TR, Deinum J, Parving HH.

    Diabetes Care. 2003 May;26(5):1501-6.PMID: 12716812 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Effect of deletion polymorphism of angiotensin converting enzyme gene on progression of diabetic nephropathy during inhibition of angiotensin converting enzyme: observational follow up study.

    Parving HH, Jacobsen P, Tarnow L, Rossing P, Lecerf L, Poirier O, Cambien F.

    BMJ. 1996 Sep 7;313(7057):591-4.PMID: 8806248 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Relationship between glomerular hyperfiltration and ACE insertion/deletion polymorphism in type 1 diabetic children and adolescents.

    Bouhanick B, Gallois Y, Hadjadj S, Boux de Casson F, Limal JM, Marre M.

    Diabetes Care. 1999 Apr;22(4):618-22.PMID: 10189542 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Enhanced responses of blood pressure, renal function, and aldosterone to angiotensin I in the DD genotype are blunted by low sodium intake.

    van der Kleij FG, de Jong PE, Henning RH, de Zeeuw D, Navis G.

    J Am Soc Nephrol. 2002 Apr;13(4):1025-33.PMID: 11912262 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Renoprotective effects of losartan in diabetic nephropathy: interaction with ACE insertion/deletion genotype?

    Andersen S, Tarnow L, Cambien F, Rossing P, Juhl TR, Deinum J, Parving HH.

    Kidney Int. 2002 Jul;62(1):192-8.PMID: 12081578 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    The influence of the ACE ( I/D) polymorphism on systemic and renal vascular responses to angiotensins in normotensive, normoalbuminuric Type 1 diabetes mellitus.

    Luik PT, Hoogenberg K, Kerstens MN, Beusekamp BJ, De Jong PE, Dullaart RP, Navis GJ.

    Diabetologia. 2003 Aug;46(8):1131-9. Epub 2003 Jul 10.PMID: 12856080 [PubMed - indexed for MEDLINE]Related articles

    13.

    Gender differences in renal responses to hyperglycemia and angiotensin-converting enzyme inhibition in diabetes.

    Cherney DZ, Sochett EB, Miller JA.

    Kidney Int. 2005 Oct;68(4):1722-8.PMID: 16164648 [PubMed - indexed for MEDLINE]Related articles

    14.

    Small doses of ramipril to reduce microalbuminuria in diabetic patients with incipient nephropathy independently of blood pressure changes.

    Marre M, Hallab M, Billiard A, Le Jeune JJ, Bled F, Girault A, Fressinaud P.

    J Cardiovasc Pharmacol. 1991;18 Suppl 2:S165-8.PMID: 1725033 [PubMed - indexed for MEDLINE]Related articles

    15.

    Reduction of ACE activity is insufficient to decrease microalbuminuria in normotensive patients with type 1 diabetes.

    Bojestig M, Karlberg BE, Lindström T, Nystrom FH.

    Diabetes Care. 2001 May;24(5):919-24.PMID: 11347755 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Angiotensin II type 1 receptor gene polymorphism and the response to hyperglycemia in early type 1 diabetes.

    Miller JA, Thai K, Scholey JW.

    Diabetes. 2000 Sep;49(9):1585-9.PMID: 10969844 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    ACE polymorphism does not determine short-term renal response to ACE-inhibition in proteinuric patients.

    van der Kleij FG, Navis GJ, Gansevoort RT, Heeg JE, Scheffer H, de Zeeuw D, de Jong PE.

    Nephrol Dial Transplant. 1997;12 Suppl 2:42-6.PMID: 9269699 [PubMed - indexed for MEDLINE]Related articles

    18.

    Angiotensin-converting enzyme insertion/deletion polymorphism and diabetic albuminuria in patients with NIDDM followed Up for 9 years.

    Huang XH, Rantalaiho V, Wirta O, Pasternack A, Hiltunen TP, Koivula T, Malminiemi K, Nikkari T, Lehtimäki T.

    Nephron. 1998 Sep;80(1):17-24.PMID: 9730698 [PubMed - indexed for MEDLINE]Related articles

    19.

    Angiotensin converting enzyme gene polymorphism and ACE inhibition in diabetic nephropathy.

    Jacobsen P, Rossing K, Rossing P, Tarnow L, Mallet C, Poirier O, Cambien F, Parving HH.

    Kidney Int. 1998 Apr;53(4):1002-6.PMID: 9551410 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Angiotensin-converting enzyme (ACE) inhibition in type 2, diabetic patients-- interaction with ACE insertion/deletion polymorphism.

    So WY, Ma RC, Ozaki R, Tong PC, Ng MC, Ho CS, Lam CW, Chow CC, Chan WB, Kong AP, Chan JC.

    Kidney Int. 2006 Apr;69(8):1438-43.PMID: 16395257 [PubMed - indexed for MEDLINE]Related articles